HAITI
Phase 2 Terminated
4 enrolled
Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer
Phase 1 Terminated
1 enrolled
FOLFIRINOX + NIS793 in Pancreatic Cancer
Phase 1 Terminated
4 enrolled
DisTinGuish
Phase 2 Terminated
247 enrolled 38 charts
SYS-CAPLIOX
Phase 1/2 Terminated
5 enrolled
Phase II Study to Assess the Efficacy of ASLAN001 Plus Capecitabine in CNS Metastases for HER2+ Breast Cancer
Phase 2 Terminated
3 enrolled
Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD
Phase 2 Terminated
17 enrolled 16 charts
Lithium
Phase 1 Terminated
2 enrolled
Comparing 177Lu-Dotatate/Capecitabine Combination Treatment With 177Lu-Dotatate in Neuroendocrine Tumor Patients
Phase 2 Terminated
111 enrolled
TUGETHER
Phase 2 Terminated
31 enrolled
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
Phase 1 Terminated
221 enrolled
Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
Terminated
2 enrolled
PERSEVERE
Phase 2 Terminated
52 enrolled 16 charts
A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC
Phase 2 Terminated
9 enrolled
SENECA
Phase 2 Terminated
53 enrolled
Lapatinib and Capecitabine for Second Line Treatment of Pancreas Cancer
Phase 2 Terminated
17 enrolled 10 charts
Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer
Phase 1 Terminated
1 enrolled 7 charts
Sunitinib and Capecitabine for First Line Colon Cancer
Phase 2 Terminated
50 enrolled 7 charts
CLavSyn
Phase 2 Terminated
54 enrolled
Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]
Phase 2 Terminated
1 enrolled 5 charts
FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer
Phase 2 Terminated
5 enrolled 11 charts
Lu-Ca-S
Phase 2 Terminated
35 enrolled
Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer
Phase 3 Terminated
340 enrolled
QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Phase 1/2 Terminated
6 enrolled 15 charts
QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
Phase 1/2 Terminated
2 enrolled 13 charts
MODULATE
Phase 1/2 Terminated
2 enrolled 7 charts
A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable, Recurrent or Metastatic Gastric Cancer or Adenocarcinoma of Gastroesophageal Junction (GEJ)
Phase 2 Terminated
29 enrolled
A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer
Phase 2/3 Terminated
130 enrolled 13 charts
PECORINO
Phase 2 Terminated
69 enrolled
Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy
Phase 2 Terminated
6 enrolled 8 charts
QUILT-3.080: NANT Pancreatic Cancer Vaccine
Phase 1/2 Terminated
3 enrolled 13 charts
QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.
Phase 1/2 Terminated
9 enrolled 18 charts
QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed
Phase 1/2 Terminated
4 enrolled 14 charts
HIGH-LIGHT
Phase 2 Terminated
21 enrolled 12 charts
Cornerstone001
Phase 2 Terminated
10 enrolled
QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Phase 1/2 Terminated
3 enrolled 9 charts
Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer
Phase 1 Terminated
3 enrolled 9 charts
QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Phase 1/2 Terminated
4 enrolled 9 charts
First-line Maintenance of OH2 Injection for Advanced Colorectal Cancer
Phase 2 Terminated
7 enrolled
A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast Cancer
Phase 3 Terminated
1 enrolled
PASIPHAE
Phase 2 Terminated
42 enrolled
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
Phase 1 Terminated
2 enrolled
Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma
Phase 1/2 Terminated
8 enrolled 14 charts
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer
Phase 2 Terminated
10 enrolled 16 charts
Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer
Phase 2 Terminated
22 enrolled 16 charts
Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery
Phase 2 Terminated
3 enrolled 6 charts
Docetaxel and Capecitabine With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Phase 2 Terminated
14 enrolled 10 charts
Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer
Phase 3 Terminated
19 enrolled
RECAP
Phase 1 Terminated
25 enrolled
Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Cancer
Phase 2 Terminated
33 enrolled